Volta System

DEVICE3 trials

Sponsors

Spark Biomedical, Inc., Five Liters, Inc.

Conditions

Blood BiomarkersHeavy Menstrual BleedingHemostasisVon Willebrand Disease, Type 1

Unknown Phase

Delivering Transcutaneous Auricular Neurostimulation to Regulate Platelet Activity in Healthy Human Subjects

CompletedNCT05977946

Spark Biomedical, Inc.Blood Biomarkers, Hemostasis

Start: 2023-10-31End: 2024-08-06Updated: 2025-04-09

Delivering Transcutaneous Auricular Neurostimulation to Reduce Heavy Menstrual Bleeding in Patients With and Without Von Willebrand Disease

CompletedNCT06064851

Five Liters, Inc.Heavy Menstrual Bleeding, Von Willebrand Disease, Type 1

Start: 2023-10-27End: 2025-04-18Updated: 2025-04-27

Transcutaneous Auricular Neurostimulation as a Treatment for Women With Heavy Menstrual Bleeding: A Dose-finding Trial

CompletedNCT06814028

Spark Biomedical, Inc.Heavy Menstrual Bleeding

Start: 2025-02-14End: 2025-09-24Updated: 2025-09-26

Related Papers

Effects of transcutaneous auricular vagus nerve stimulation or combined vagal and trigeminal nerve stimulation on platelet function and laboratory hemostasis parameters in healthy human subjects

Bioelectronic Medicine2026-06-04

Transcutaneous auricular neurostimulation to reduce heavy menstrual bleeding in women with and without von Willebrand disease.

2025-10-081 citations